Guardion Health Sciences Inc (GHSI) |
|
0.7444 -0.037 (-4.67%)
|
02-25 11:01 |
|
Open: |
0.7539 |
Pre. Close: |
0.7809 |
|
High:
|
0.7747 |
Low:
|
0.72 |
|
Volume:
|
10,376,868 |
Market Cap:
|
81M |
|
|
|
|
Guardion Health Sciences, Inc. engages in the provision of health care services. The company is headquartered in San Diego, California and currently employs 94 full-time employees. The firm operates through two segments: Medical Foods and Vision Testing Diagnostics. Medical Foods segment develops, formulates and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z that replenishes and restores the macular protective pigment. The company has also developed a technology, the MapcatSF, which measures the macular pigment optical density (MPOD). The company also provides GlaucoCetin, which is the vision-specific medical food designed to support and protect the mitochondrial function of optic nerve cells and improves blood flow in the ophthalmic artery in patients with glaucoma. The Company’s Vision Testing Diagnostics segment operates under the brand name VectorVision. The company specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity and early treatment diabetic retinopathy study (ETDRS) visual acuity testing. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.841 - 0.846 |
0.846 - 0.85 |
|
Low:
|
0.758 - 0.764 |
0.764 - 0.769 |
|
Close:
|
0.772 - 0.78 |
0.78 - 0.788 |
|
Technical analysis |
as of: 2021-02-25 10:38:10 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.30 One year: 1.64 |
| Support: |
Support1: 0.65 Support2: 0.54 |
| Resistance: |
Resistance1: 1.11 Resistance2: 1.40 |
| Pivot: |
0.97  |
| Moving Average: |
MA(5): 0.88 MA(20): 0.93
MA(100): 0.45  MA(250): 0.42 |
| MACD: |
MACD(12,26): 0.05 Signal(9): 0.10 |
| Stochastic oscillator: |
%K(14,3): 6.46 %D(3): 22.16 |
| RSI: |
RSI(14): 42.28 |
| 52-week: |
High: 1.40 Low: 0.17 Change(%): 71.7 |
| Average Vol(K): |
3-Month: 3188342 10-Days: 2295459 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.GHSI has closed above bottom band by 10.5%. Bollinger Bands are 165.6% wider than normal. The large width of the bands suggest high volatility as compared to GHSI's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 09 Feb 2021
Should You Buy Guardion Health Sciences Inc (GHSI) Stock on Tuesday? - InvestorsObserver
Thu, 28 Jan 2021
Malaysia's Ho Wah Genting Berhad Advises Guardion Health Sciences That It Has received Regulatory Product Registration Approval for Second Immune Support Dietary Supplement Designed and Produced by Guardion Health Sciences - GlobeNewswire
Wed, 27 Jan 2021
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule - GlobeNewswire
Fri, 15 Jan 2021
The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More - Simply Wall St
Wed, 06 Jan 2021
GHSI Stock: 11 Things for Investors to Know About Guardion Health Sciences - InvestorPlace
Wed, 06 Jan 2021
Should Guardion Health Sciences (NASDAQ:GHSI) Be Disappointed With Their 94% Profit? - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
92 |
| Shares Float (M) |
76 |
|
% Held by Insiders
|
3.89 |
|
% Held by Institutions
|
5.04 |
|
Shares Short (K)
|
3,750 |
|
Shares Short P. Month (K)
|
409 |
Stock Financials |
|
EPS
|
-0.116 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.120 |
|
Profit Margin
|
|
|
Operating Margin
|
-419.83 |
|
Return on Assets (ttm)
|
-47.9 |
|
Return on Equity (ttm)
|
-98.8 |
|
Qtrly Rev. Growth
|
57.1 |
|
Gross Profit (p.s.)
|
0.006 |
|
Sales Per Share
|
0.021 |
|
EBITDA (p.s.)
|
-0.087 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-8 |
|
Levered Free Cash Flow (M)
|
-5 |
Stock Valuations |
|
PE Ratio
|
-6.27 |
|
PEG Ratio
|
|
|
Price to Book value
|
6.07 |
|
Price to Sales
|
34.54 |
|
Price to Cash Flow
|
-8.68 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
